The Pathophysiology of IgAN and Use of Immunomodulating Therapies
An expert nephrologist provides an overview of the pathophysiology of IgAN before discussing new immunomodulating therapies in clinical trials.
Chee Kay Cheung European Renal Association Visionary Study Pro Inflammatory Effect Mesangial Cell Activation B Cell
Source: hcplive.com